Long-term health and fertility study for women with breast cancer
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy, Skin clinical trials.
This study follows women with breast cancer and certain lymphomas to understand long-term sexual and reproductive health. It may help researchers better support patients’ body changes and wellness over time during and after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You are able to read/speak English and join the consent process
- You have been diagnosed with early breast cancer (stage 0 to III) or an aggressive lymphoma treated with curative first-line therapy
- You are either premenopausal (had a period in the last 12 months or were pregnant) or postmenopausal (no period for 2+ years)
- If you have breast cancer and want the tamoxifen-only part: you plan to start tamoxifen within 1 month and haven’t started treatment yet
- You have not had prior cancer treatment with medications, and you don’t have a second cancer that needs chemo
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures blood biomarkers to understand how breast cancer treatment affects a person’s future fertility (ovarian reserve). It may help patients learn more about egg supply changes after chemotherapy and hormone-related treatments.
This follow-up study is for people who took part in earlier breast cancer gene tests (TAILORx or RxPONDER). It collects health information and tumor tissue over time to learn more about how breast cancer behaves after treatment.
This study looks at how your immune system changes while you receive standard breast cancer treatments. The researchers measure immune-related signals during your treatment to better understand what may be happening in triple-negative or certain hormone-receptor breast cancers.
This study looks at whether taking hormone-blocking pills for longer than 5 years can help lower the risk of breast cancer returning. It is for people who had lymph node involvement and have already completed their initial 5-year treatment without the cancer coming back.
This study looks at how the immune system changes in people with breast cancer, using patient tissue samples. It may help researchers understand immune responses in young women and guide future cancer treatments.
This study looks at a patient-led follow-up approach after early breast cancer treatment, where you may have more control and flexibility instead of routine hospital visits, while still on hormone therapy.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.